Providing an update of the ongoing mpox outbreak and discussing the potential use of vaccines to combat it.
In August 2024, the WHO announced the ongoing mpox outbreak to be a public health emergency of international concern following a surge in cases across Africa and the emergence of a new sexually transmitted strain of the virus. This announcement has been followed by an escalation in measures to prepare for and respond to the ongoing outbreak.
Mpox vaccines offer protection against infection and severe disease. The WHO currently recommends two vaccines against mpox (MVA-BN and LC16) or a third (ACAM2000) when the others are not available.
But with a shortage of doses alongside renewed concerns of ‘vaccine hoarding’, it is unclear what role vaccines will play in the global response to the current outbreak.
In this special Vaccine Centre seminar, we will provide an update of the current mpox outbreak and the potential use of vaccines to combat the spread of the virus.
Topics will include:
- An update on the current outbreak;
- Ongoing mpox research in Nigeria;
- Vaccine implementation and effectiveness in the UK;
- What vaccines are currently available and in what quantities;
- The optimal use of available doses given supply constraints.
We invite attendees to join us after the seminar for drinks and networking in the Pumphandle Social.
Speakers
Professor David Heymann
Dr Chioma Achi
Chioma joined the Department of Infectious Disease Epidemiology at LSHTM as an Assistant Professor in August 2024. She coordinates the Mpox research project, a research collaboration between the LSHTM, UK-Public Health Rapid Support Team (UK-PHRST), the University of Oxford and ODA-partners. Chioma has experience working in One Health and epidemiology, an area where she also completed her PhD. She holds a PhD from the University of Cambridge, an MSc in Applied Microbiology and Biotechnology from the University of Westminster, London where she worked on Bundibugyo Ebolavirus and a Doctor of Veterinary Medicine (DVM) degree from Ahmadu Bello University, Zaria Nigeria. Her other research interests are around Antimicrobial Resistance, Bacterial Genomics, Zoonoses and Food Safety.
Dr Hannah Charles
Hannah Charles has a background in public health and microbiology, and is currently a Principal Epidemiologist at the UK Health Security Agency. Her work focused on the real-time and enhanced surveillance of sexually transmitted infections, and has involved responding to the mpox outbreak in England.
Event notices
- Please note that you can join this event in person or you can join the session remotely.
- Please note that the recording link will be listed on this page when available.
Admission
Contact
